Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
2
×
boston top stories
casdin capital
2
×
clinical trials
life sciences
national blog main
national top stories
abbvie
aimmune therapeutics
akcea therapeutics
akebia therapeutics
alex pinto
ally bridge group
amarin pharma
amarna therapeutics
amylyx
amyotrophic lateral sclerosis (als)
anemia
antibody drug
big data analytics
biofourmis
blackrock
boston
boston pharmaceuticals
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
chronic kidney disease
clene nanomedicine
corvex management
covid-19
cystic fibrosis
detroit blog main
detroit top stories
diabetic nephropathy
digital therapeutics
dov goldstein
ed rebar
europe blog main
What
bio
abbvie’s
ahead
analysis
biofourmis
biotech
bring
bucks
cancer
celebrate
chance
company
corner
day
days
develop
diseases
drug
employing
forward
genetic
goldfinch
holiday
ipo
kidney
labor
later
lead
looking
medicines
million
new
people
pharma
raised
raises
roundup
studies
summer
waning
Language
unset
Current search:
" boston blog main "
×
" casdin capital "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later